Retrospective Visibility of Metastatic Epidural Extension on Unenhanced CT

Background/Objectives: This study evaluated the retrospective visibility of metastatic epidural extension on unenhanced computed tomography (CT) in patients with known spinal metastases. Methods: This retrospective single-center cohort included 98 patients. Epidural extension, with or without neural compression, was determined from clinical MRI (79 patients) or contrast-enhanced CT alone (19 patients). Two spine surgeons independently reviewed the unenhanced CT closest in date to the reference examination, blinded to the imaging diagnosis and lesion location. CT findings were positive if either reader identified a lesion. Earlier CTs were reviewed only after a positive initial assessment, with knowledge of the identified lesion. Surgical and survival comparisons were secondary, exploratory, and unadjusted. Results: Epidural lesions were retrospectively visible in 39/50 reference-positive patients (78.0%), including 19/23 with Bilsky grades II–III (82.6%). One of the 48 reference-negative patients had a positive CT finding. Interobserver agreement was 92.9% (κ = 0.847). The interval from initial CT to reference imaging was a median of 1 day (range, 0–58) in CT-visible cases and 3 days (range, 0–160) in CT-nonvisible cases. Within 7 days, lesions were visible in 25/33 patients (75.8%). In the selected backward review, lesions were visible before reference diagnosis in 24/50 patients (48.0%); the interval from the earliest positive CT was a median of 30 days (range, 1–542). Exploratory comparisons showed surgical proportions of 48.3% versus 14.3% for Bilsky Ic–III versus Ia–Ib (p = 0.0277), without a statistically significant unadjusted survival difference (p = 0.0911). Conclusions: Metastatic epidural extension was retrospectively visible on unenhanced CT in this selected cohort. Earlier retrospective visibility does not establish prospective detectability or improved treatment or neurological outcomes from earlier recognition.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-17
DOI
https://doi.org/10.3390/diagnostics16223825
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Retrospective Visibility of Metastatic Epidural Extension on Unenhanced CT

Yoshiaki Oda, Toshifumi Ozaki, Kazutaka Yamashita, Kensuke Shinohara et al.
Diagnostics
Management of metastatic bone disease
article

Retrospective Visibility of Metastatic Epidural Extension on Unenhanced CT

Yoshiaki Oda, Toshifumi Ozaki, Kazutaka Yamashita, Kensuke Shinohara, Hironori Tsuji, Koji Uotani, Shinsuke Sugihara, Ryo Takatori, Kenzaburou Matsumoto
article en

Abstract

Background/Objectives: This study evaluated the retrospective visibility of metastatic epidural extension on unenhanced computed tomography (CT) in patients with known spinal metastases. Methods: This retrospective single-center cohort included 98 patients. Epidural extension, with or without neural compression, was determined from clinical MRI (79 patients) or contrast-enhanced CT alone (19 patients). Two spine surgeons independently reviewed the unenhanced CT closest in date to the reference examination, blinded to the imaging diagnosis and lesion location. CT findings were positive if either reader identified a lesion. Earlier CTs were reviewed only after a positive initial assessment, with knowledge of the identified lesion. Surgical and survival comparisons were secondary, exploratory, and unadjusted. Results: Epidural lesions were retrospectively visible in 39/50 reference-positive patients (78.0%), including 19/23 with Bilsky grades II–III (82.6%). One of the 48 reference-negative patients had a positive CT finding. Interobserver agreement was 92.9% (κ = 0.847). The interval from initial CT to reference imaging was a median of 1 day (range, 0–58) in CT-visible cases and 3 days (range, 0–160) in CT-nonvisible cases. Within 7 days, lesions were visible in 25/33 patients (75.8%). In the selected backward review, lesions were visible before reference diagnosis in 24/50 patients (48.0%); the interval from the earliest positive CT was a median of 30 days (range, 1–542). Exploratory comparisons showed surgical proportions of 48.3% versus 14.3% for Bilsky Ic–III versus Ia–Ib (p = 0.0277), without a statistically significant unadjusted survival difference (p = 0.0911). Conclusions: Metastatic epidural extension was retrospectively visible on unenhanced CT in this selected cohort. Earlier retrospective visibility does not establish prospective detectability or improved treatment or neurological outcomes from earlier recognition.

DiagnosticsVol. 16(22)
Okayama University (JP), Okayama University Hospital (JP), Shikoku Cancer Center (JP)
Good health and well-being
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon